- PCR
- NGS
- FISH
- IHC
- Others
| 1. Executive Summary |
| 2. Poland Non-Small Cell Lung Cancer (NSCLC) Market Introduction |
| 2.1. Poland Non-Small Cell Lung Cancer (NSCLC) Market Taxonomy |
| 2.2. Poland Non-Small Cell Lung Cancer (NSCLC) Market Definitions |
| 2.2.1. Molecular Test |
| 2.2.2. Collection Type |
| 2.2.3. Cancer Type |
| 3. Poland Non-Small Cell Lung Cancer (NSCLC) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Collaborations, Acquisitions and Mergers |
| 3.6. Poland Non-Small Cell Lung Cancer (NSCLC) Market Competition Landscape |
| 3.7. Poland Non-Small Cell Lung Cancer (NSCLC) Market Dynamic Factors - Impact Analysis |
| 4. Poland Non-Small Cell Lung Cancer (NSCLC) Market Analysis, 2019-2023 and Forecast, 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Poland Non-Small Cell Lung Cancer (NSCLC) Market, By Molecular Test Platform, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1. PCR |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. NGS |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. FISH |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. IHC |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Collection Type, 2019-2023 and Forecast, 2024-2030 |
| 6.1. Mediastinoscopy |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bronchoscopy |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Needle Biopsy |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Cancer Type, 2019-2023 and Forecast, 2024-2030 |
| 7.1. Adenocarcinoma |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Squamous Cell Carcinoma |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Large Cell Carcinoma |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Adenosquamous Carcinoma |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Research Methodology |
| 9. Key Assumptions and Acronyms |
Poland Non Small Cell Lung Cancer Nsclc Market Segmentation
By Molecular Test
By Collection Type
- Mediastinoscopy
- Bronchoscopy
- Needle Biopsy
- Others
By Cancer Type
- Adenocarcinoma
- Squamous Cell Carcinoma
- Large Cell Carcinoma
- Adenosquamous Carcinoma
- Others
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- Albemarle Corporation
- Chemtura Corporation
- Baerlocher GmbH
- BASF
- Clariant
- ADEKA Corporation
- Sumitomo Chemical Co., Ltd
- The DOW Chemical Company
- Akzonobel NV
- Evonik Industries AG
- Kaneka Corporation
- Songwon Industrial Co., Ltd
- Mitsui & Co., Ltd. Co., Ltd.